Premium
Vardenafil, a clinically available phosphodiesterase inhibitor, potentiates the killing effect of EGCG on CLL cells
Author(s) -
Kumazoe Motofumi,
Tsukamoto Shuntaro,
Lesnick Connie,
Kay Neil E.,
Yamada Koji,
Shanafelt Tait D.,
Tachibana Hirofumi
Publication year - 2015
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.13135
Subject(s) - cd19 , medicine , antigen , immunology , cd38 , cancer research , microbiology and biotechnology , biology , stem cell , cd34 , genetics